Pharma Stocks
-
Is its pharma packaging dominance strong enough for steady gro
Gerresheimer AG specializes in critical packaging for pharmaceuticals, offering you exposure to resilient healthcare demand that underpins portfolios amid economic…
Read More » -
Does Amneal Pharmaceuticals’ (AMRX) Inhaler Push Reveal a Durable Edge in Complex Generics?
Earlier in April 2026, Amneal Pharmaceuticals launched its first U.S. metered-dose inhalers, generic versions of PROAIR HFA and the original…
Read More » -
Is its pharmacy distribution model strong enough for steady growth?
Neuca S.A. dominates Poland’s pharmaceutical wholesale market, but does this niche focus deliver reliable returns for you as an investor…
Read More » -
Is its NASH pipeline strong enough to unlock biotech up
Hepion Pharmaceuticals focuses on innovative treatments for metabolic liver diseases like NASH, offering U.S. investors targeted exposure to a high-growth…
Read More » -
We’re Hopeful That Solasia Pharma K.K (TSE:4597) Will Use Its Cash Wisely
Even when a business is losing money, it’s possible for shareholders to make money if they buy a good business…
Read More » -
Is pharma packaging demand strong enough to drive steady gains
With global pharma growth accelerating amid AI-driven drug discovery and supply chain shifts, can Gerresheimer’s specialized packaging position deliver reliable…
Read More » -
Amneal shares rise after UBS initiates at Buy, cites “best-in-group” growth in specialty pharma
Amneal shares rise after UBS initiates at Buy, cites “best-in-group” growth in specialty pharma Proactive uses images sourced from Shutterstock…
Read More » -
Should Investors Buy the Dip or Exit Amid AI Drug R&D Impact?
TradingKey – On April 16, 2026, OpenAI released GPT-Rosalind, a large language model specifically designed for life sciences research. Initial…
Read More » -
Top stocks in news: Wipro, HDFC Life, Jio Financial, Auro Pharma, RVNL, AngelOne, Om Power
Indian benchmark indices settled lower, giving up early gains in the fag end of the session, as trader book profits…
Read More » -
3 Under-the-Radar Healthcare Stocks Worth Adding to Your Watchlist
Key Points All three drugmakers have proven fairly innovative in their respective niches. Clinical and commercial progress could send their…
Read More »